A 79-year-old man may have been in a state of paranoia or confusion from cancer treatment or his impending death when police say he attacked his wife with a knife and hammer last month in ...

Amgen reported progress across its KRAS inhibitor portfolio, including Lumakras and next generation candidates such as AMG ...

A 79-year-old man may have been in a state of paranoia or confusion from cancer treatment or his impending death when police say he attacked his wife with a knife ...

Leerink Global Healthcare Conference 2026 March 11, 2026 9:20 AM EDTCompany ParticipantsJasper Van GrunsvenPeter Griffith - Executive ...

The price for the same prescription drug in different hospitals nationwide could have more than a $10,000 difference, according to a new report. A report from 3 Axis Advisors used publicly available ...

The price for the same prescription drug in different hospitals nationwide could have more than a $10,000 difference, according to a new report.

Ipilimumab-nivolumab also linked with better survival but more toxicity in small study ...

Akeso (SEHK:9926) reported long term survival data from a Phase II study of cadonilimab in advanced cervical cancer, highlighting durable benefits in a setting with limited treatment options. The ...

A handful of the industry's income-generating gems are hiding in plain sight.

The Citizens Life Sciences Conference 2026 March 11, 2026 10:45 AM EDTCompany ParticipantsHelen Torley - President, ...

Pfizer PFE faces several near-term challenges like declining COVID sales, the upcoming loss of exclusivity (“LOE”) cliff and U.S. Medicare Part D headwinds. These headwinds can hurt its sales and ...

Overall survival similarly tracked tumor shrinkage, with 4-year OS of 84.3% (CR), 67.4% (PR1), 55.6% (PR2), 41.6% (PR3), 29.2% (SD), and 20.0% (PD). Median DOR was not reached in CR, approximately 22 ...